StockData
Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc. (RCKT) stock

RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$2.11+0.00 (0.00%)

Close on Nov 18, 2026Market cap $231.62MP/E –Yield –

Earnings

Rocket Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 25, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.43
-$0.45 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Rocket Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 25, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026after the close––-$0.43Release
Q2 FY2026ended Jun 30, 2026Aug 10, 2026after the close––$1.08Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close––-$0.42Release
Q4 FY2025ended Dec 31, 2025Feb 26, 2026after the close––-$0.38Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close––-$0.45Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025after the close––-$0.62Release
Q1 FY2025ended Mar 31, 2025May 8, 2025after the close––-$0.56Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025after the close––-$0.62Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024after the close––-$0.71Release
Q2 FY2024ended Jun 30, 2024Aug 5, 2024after the close––-$0.74Release
Q1 FY2024ended Mar 31, 2024May 6, 2024after the close––-$0.66Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Rocket Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Rocket Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Rocket Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. Update
  5. Results
  6. Update
  7. Update
  8. Results
  9. Update
  10. Update
  11. Results
  12. Results
  13. News
  14. News
  15. Results

See a number that looks wrong?